StockData
BrainStorm Cell Therapeutics Inc. logo

BrainStorm Cell Therapeutics Inc. (BCLI) cash flow statement

BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.77−0.01 (-1.17%)

Close on Oct 19, 2026Market cap $8.50MP/E –Yield –

BrainStorm Cell Therapeutics Inc. cash flow statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
116.1%

Financial strength

Current ratio
0.03
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?